Iovance Biotherapeutics Inc IOVA shares are trading lower by 15.8% to $4.58, despite a lack of company-specific news for the session. The stock is falling on heavy volume Thursday morning with nearly 4 million shares exchanging hands, and fast approaching the trailing 100 day average volume of 4.8 million shares.
The stock may be falling on continued weakness following Wednesday's session after Stifel analyst Benjamin Burnett maintained shares with a Buy and lowered the price target from $27 to $25.
Additionally, the company last week presented at the 2023 Wells Fargo Healthcare Conference.
See Also: Producer Prices Unexpectedly Soar 1.6% In August
According to data from Benzinga Pro, IOVA has a 52-week high of $13.32 and a 52-week low of $4.41.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
